Literature DB >> 16963591

Preliminary FMRI evidence of visual system dysfunction in Parkinson's disease patients with visual hallucinations.

Suzanne Holroyd1, G Frederick Wooten.   

Abstract

Using functional magnetic resonance imaging (fMRI), the authors examined visual cortex function in Parkinson's disease patients who did and did not experience visual hallucinations. Patients with visual hallucinations demonstrated increased activation in the visual association cortex and deficits in the primary visual cortex, suggesting that visual hallucinations are associated with an abnormality of visual-cortex function.

Entities:  

Mesh:

Year:  2006        PMID: 16963591     DOI: 10.1176/jnp.2006.18.3.402

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  17 in total

Review 1.  [Parkinson's disease and psychoses].

Authors:  Jacopo Vittoriano Bizzarri; Giancarlo Giupponi; Ignazio Maniscalco; Patrizia Schroffenegger; Andreas Conca; Hans Peter Kapfhammer
Journal:  Neuropsychiatr       Date:  2015-01-14

2.  Visual hallucinations are associated with hyperconnectivity between the amygdala and visual cortex in people with a diagnosis of schizophrenia.

Authors:  Judith M Ford; Vanessa A Palzes; Brian J Roach; Steven G Potkin; Theo G M van Erp; Jessica A Turner; Bryon A Mueller; Vincent D Calhoun; Jim Voyvodic; Aysenil Belger; Juan Bustillo; Jatin G Vaidya; Adrian Preda; Sarah C McEwen; Daniel H Mathalon
Journal:  Schizophr Bull       Date:  2014-03-11       Impact factor: 9.306

Review 3.  Interaction Between Neuropsychiatric Symptoms and Cognitive Performance in Parkinson's Disease: What Do Clinical and Neuroimaging Studies Tell Us?

Authors:  Alexandru Hanganu; Oury Monchi
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-15       Impact factor: 5.081

4.  Rhythmic movement in Parkinson's disease: effects of visual feedback and medication state.

Authors:  S Levy-Tzedek; H I Krebs; J E Arle; J L Shils; H Poizner
Journal:  Exp Brain Res       Date:  2011-04-28       Impact factor: 1.972

Review 5.  Pathophysiology and treatment of psychosis in Parkinson's disease: a review.

Authors:  Laura B Zahodne; Hubert H Fernandez
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 6.  Recent advances in the neuropsychopharmacology of serotonergic hallucinogens.

Authors:  Adam L Halberstadt
Journal:  Behav Brain Res       Date:  2014-07-15       Impact factor: 3.332

Review 7.  Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.

Authors:  Anna Chang; Susan H Fox
Journal:  Drugs       Date:  2016-07       Impact factor: 9.546

8.  Cognitive correlates of cerebellar resting-state functional connectivity in Parkinson disease.

Authors:  Baijayanta Maiti; Jonathan M Koller; Abraham Z Snyder; Aaron B Tanenbaum; Scott A Norris; Meghan C Campbell; Joel S Perlmutter
Journal:  Neurology       Date:  2019-12-17       Impact factor: 9.910

Review 9.  The psychosis spectrum in Parkinson disease.

Authors:  Dominic H Ffytche; Byron Creese; Marios Politis; K Ray Chaudhuri; Daniel Weintraub; Clive Ballard; Dag Aarsland
Journal:  Nat Rev Neurol       Date:  2017-01-20       Impact factor: 42.937

10.  Increasing Contrast Improves Object Perception in Parkinson's Disease with Visual Hallucinations.

Authors:  Mirella Díaz-Santos; Zachary A Monge; Robert D Salazar; Grover C Gilmore; Sandy Neargarder; Alice Cronin-Golomb
Journal:  Mov Disord Clin Pract       Date:  2020-11-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.